nodes	percent_of_prediction	percent_of_DWPC	metapath
Crizotinib—EPHB4—Axon guidance—COL9A3—degenerative disc disease	0.00409	0.00409	CbGpPWpGaD
Crizotinib—MET—Axon guidance—COL9A2—degenerative disc disease	0.00404	0.00404	CbGpPWpGaD
Crizotinib—LIMK1—Axon guidance—COL9A3—degenerative disc disease	0.004	0.004	CbGpPWpGaD
Crizotinib—MAPK7—BDNF signaling pathway—BMP2—degenerative disc disease	0.00397	0.00397	CbGpPWpGaD
Crizotinib—JAK2—NCAM signaling for neurite out-growth—COL9A2—degenerative disc disease	0.00387	0.00387	CbGpPWpGaD
Crizotinib—JAK3—Oncostatin M Signaling Pathway—MMP3—degenerative disc disease	0.00385	0.00385	CbGpPWpGaD
Crizotinib—SRC—NCAM signaling for neurite out-growth—COL9A3—degenerative disc disease	0.00385	0.00385	CbGpPWpGaD
Crizotinib—EPHB6—Axon guidance—COL9A3—degenerative disc disease	0.00384	0.00384	CbGpPWpGaD
Crizotinib—MET—Developmental Biology—COL9A3—degenerative disc disease	0.00369	0.00369	CbGpPWpGaD
Crizotinib—TYK2—Oncostatin M Signaling Pathway—MMP13—degenerative disc disease	0.00365	0.00365	CbGpPWpGaD
Crizotinib—MAP3K2—BDNF signaling pathway—BMP2—degenerative disc disease	0.00362	0.00362	CbGpPWpGaD
Crizotinib—EPHA6—Axon guidance—COL9A3—degenerative disc disease	0.00361	0.00361	CbGpPWpGaD
Crizotinib—FES—Axon guidance—COL9A2—degenerative disc disease	0.00353	0.00353	CbGpPWpGaD
Crizotinib—CASK—Extracellular matrix organization—MMP13—degenerative disc disease	0.00342	0.00342	CbGpPWpGaD
Crizotinib—PTK2B—Oncostatin M Signaling Pathway—MMP3—degenerative disc disease	0.00338	0.00338	CbGpPWpGaD
Crizotinib—EPHA3—Axon guidance—COL9A2—degenerative disc disease	0.00334	0.00334	CbGpPWpGaD
Crizotinib—ABL2—Axon guidance—COL9A2—degenerative disc disease	0.00334	0.00334	CbGpPWpGaD
Crizotinib—EPHA5—Axon guidance—COL9A2—degenerative disc disease	0.00334	0.00334	CbGpPWpGaD
Crizotinib—EPHA2—Axon guidance—COL9A3—degenerative disc disease	0.00333	0.00333	CbGpPWpGaD
Crizotinib—ACVR1B—Developmental Biology—COL9A2—degenerative disc disease	0.00332	0.00332	CbGpPWpGaD
Crizotinib—CASK—Extracellular matrix organization—BMP2—degenerative disc disease	0.0033	0.0033	CbGpPWpGaD
Crizotinib—RIPK2—p75(NTR)-mediated signaling—MMP3—degenerative disc disease	0.00327	0.00327	CbGpPWpGaD
Crizotinib—EPHA8—Axon guidance—COL9A2—degenerative disc disease	0.00323	0.00323	CbGpPWpGaD
Crizotinib—FES—Developmental Biology—COL9A3—degenerative disc disease	0.00323	0.00323	CbGpPWpGaD
Crizotinib—LIMK2—Axon guidance—COL9A2—degenerative disc disease	0.00319	0.00319	CbGpPWpGaD
Crizotinib—EPHA4—Axon guidance—COL9A2—degenerative disc disease	0.00319	0.00319	CbGpPWpGaD
Crizotinib—EPHB4—Axon guidance—COL9A2—degenerative disc disease	0.00319	0.00319	CbGpPWpGaD
Crizotinib—LIMK1—Axon guidance—COL9A2—degenerative disc disease	0.00312	0.00312	CbGpPWpGaD
Crizotinib—NTRK1—p75(NTR)-mediated signaling—MMP3—degenerative disc disease	0.00308	0.00308	CbGpPWpGaD
Crizotinib—EPHA5—Developmental Biology—COL9A3—degenerative disc disease	0.00306	0.00306	CbGpPWpGaD
Crizotinib—EPHA3—Developmental Biology—COL9A3—degenerative disc disease	0.00306	0.00306	CbGpPWpGaD
Crizotinib—ABL2—Developmental Biology—COL9A3—degenerative disc disease	0.00306	0.00306	CbGpPWpGaD
Crizotinib—SRC—Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling—MMP13—degenerative disc disease	0.00304	0.00304	CbGpPWpGaD
Crizotinib—SRC—NCAM signaling for neurite out-growth—COL9A2—degenerative disc disease	0.003	0.003	CbGpPWpGaD
Crizotinib—EPHB6—Axon guidance—COL9A2—degenerative disc disease	0.003	0.003	CbGpPWpGaD
Crizotinib—TYK2—Signaling by PDGF—COL9A3—degenerative disc disease	0.00298	0.00298	CbGpPWpGaD
Crizotinib—EPHA8—Developmental Biology—COL9A3—degenerative disc disease	0.00295	0.00295	CbGpPWpGaD
Crizotinib—LIMK2—Developmental Biology—COL9A3—degenerative disc disease	0.00292	0.00292	CbGpPWpGaD
Crizotinib—EPHA4—Developmental Biology—COL9A3—degenerative disc disease	0.00292	0.00292	CbGpPWpGaD
Crizotinib—EPHB4—Developmental Biology—COL9A3—degenerative disc disease	0.00292	0.00292	CbGpPWpGaD
Crizotinib—MET—Developmental Biology—COL9A2—degenerative disc disease	0.00288	0.00288	CbGpPWpGaD
Crizotinib—LIMK1—Developmental Biology—COL9A3—degenerative disc disease	0.00285	0.00285	CbGpPWpGaD
Crizotinib—EPHA6—Axon guidance—COL9A2—degenerative disc disease	0.00282	0.00282	CbGpPWpGaD
Crizotinib—JAK2—Oncostatin M Signaling Pathway—MMP13—degenerative disc disease	0.00277	0.00277	CbGpPWpGaD
Crizotinib—EPHB6—Developmental Biology—COL9A3—degenerative disc disease	0.00274	0.00274	CbGpPWpGaD
Crizotinib—JAK2—AGE/RAGE pathway—MMP13—degenerative disc disease	0.00273	0.00273	CbGpPWpGaD
Crizotinib—EPHA2—Axon guidance—COL9A2—degenerative disc disease	0.0026	0.0026	CbGpPWpGaD
Crizotinib—PTK2B—BDNF signaling pathway—BMP2—degenerative disc disease	0.00258	0.00258	CbGpPWpGaD
Crizotinib—EPHA6—Developmental Biology—COL9A3—degenerative disc disease	0.00258	0.00258	CbGpPWpGaD
Crizotinib—FES—Developmental Biology—COL9A2—degenerative disc disease	0.00252	0.00252	CbGpPWpGaD
Crizotinib—ABL1—Posttranslational regulation of adherens junction stability and dissassembly—MMP3—degenerative disc disease	0.00251	0.00251	CbGpPWpGaD
Crizotinib—NTRK1—BDNF signaling pathway—BMP2—degenerative disc disease	0.00247	0.00247	CbGpPWpGaD
Crizotinib—TYK2—Oncostatin M Signaling Pathway—MMP3—degenerative disc disease	0.00244	0.00244	CbGpPWpGaD
Crizotinib—IRAK1—p75(NTR)-mediated signaling—MMP3—degenerative disc disease	0.0024	0.0024	CbGpPWpGaD
Crizotinib—RPS6KB1—BDNF signaling pathway—BMP2—degenerative disc disease	0.00239	0.00239	CbGpPWpGaD
Crizotinib—EPHA3—Developmental Biology—COL9A2—degenerative disc disease	0.00239	0.00239	CbGpPWpGaD
Crizotinib—ABL2—Developmental Biology—COL9A2—degenerative disc disease	0.00239	0.00239	CbGpPWpGaD
Crizotinib—EPHA5—Developmental Biology—COL9A2—degenerative disc disease	0.00239	0.00239	CbGpPWpGaD
Crizotinib—EPHA2—Developmental Biology—COL9A3—degenerative disc disease	0.00238	0.00238	CbGpPWpGaD
Crizotinib—TYK2—Signaling by PDGF—COL9A2—degenerative disc disease	0.00232	0.00232	CbGpPWpGaD
Crizotinib—EPHA8—Developmental Biology—COL9A2—degenerative disc disease	0.0023	0.0023	CbGpPWpGaD
Crizotinib—CASK—Extracellular matrix organization—MMP3—degenerative disc disease	0.00229	0.00229	CbGpPWpGaD
Crizotinib—EPHA4—Developmental Biology—COL9A2—degenerative disc disease	0.00228	0.00228	CbGpPWpGaD
Crizotinib—LIMK2—Developmental Biology—COL9A2—degenerative disc disease	0.00228	0.00228	CbGpPWpGaD
Crizotinib—EPHB4—Developmental Biology—COL9A2—degenerative disc disease	0.00228	0.00228	CbGpPWpGaD
Crizotinib—JAK2—Signaling by PDGF—COL9A3—degenerative disc disease	0.00226	0.00226	CbGpPWpGaD
Crizotinib—PRKD1—Metabolism—CHST3—degenerative disc disease	0.00223	0.00223	CbGpPWpGaD
Crizotinib—LIMK1—Developmental Biology—COL9A2—degenerative disc disease	0.00223	0.00223	CbGpPWpGaD
Crizotinib—SRC—Oncostatin M Signaling Pathway—MMP13—degenerative disc disease	0.00214	0.00214	CbGpPWpGaD
Crizotinib—EPHB6—Developmental Biology—COL9A2—degenerative disc disease	0.00214	0.00214	CbGpPWpGaD
Crizotinib—SRC—AGE/RAGE pathway—MMP13—degenerative disc disease	0.00212	0.00212	CbGpPWpGaD
Crizotinib—PTK2—Axon guidance—COL9A3—degenerative disc disease	0.00207	0.00207	CbGpPWpGaD
Crizotinib—YES1—Axon guidance—COL9A3—degenerative disc disease	0.00204	0.00204	CbGpPWpGaD
Crizotinib—SRC—Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling—MMP3—degenerative disc disease	0.00204	0.00204	CbGpPWpGaD
Crizotinib—EPHA6—Developmental Biology—COL9A2—degenerative disc disease	0.00201	0.00201	CbGpPWpGaD
Crizotinib—MAPK7—Gastrin-CREB signalling pathway via PKC and MAPK—MMP3—degenerative disc disease	0.002	0.002	CbGpPWpGaD
Crizotinib—STK4—Signaling Pathways—COL9A3—degenerative disc disease	0.00199	0.00199	CbGpPWpGaD
Crizotinib—LCK—Signaling by PDGF—COL9A3—degenerative disc disease	0.00198	0.00198	CbGpPWpGaD
Crizotinib—TYK2—Axon guidance—COL9A3—degenerative disc disease	0.00188	0.00188	CbGpPWpGaD
Crizotinib—CYP3A5—Metapathway biotransformation—CHST3—degenerative disc disease	0.00187	0.00187	CbGpPWpGaD
Crizotinib—EPHA2—Developmental Biology—COL9A2—degenerative disc disease	0.00186	0.00186	CbGpPWpGaD
Crizotinib—JAK2—Oncostatin M Signaling Pathway—MMP3—degenerative disc disease	0.00185	0.00185	CbGpPWpGaD
Crizotinib—SRC—Posttranslational regulation of adherens junction stability and dissassembly—MMP3—degenerative disc disease	0.00183	0.00183	CbGpPWpGaD
Crizotinib—JAK2—Signaling by PDGF—COL9A2—degenerative disc disease	0.00176	0.00176	CbGpPWpGaD
Crizotinib—SRC—Signaling by PDGF—COL9A3—degenerative disc disease	0.00175	0.00175	CbGpPWpGaD
Crizotinib—STK3—Signaling Pathways—COL9A3—degenerative disc disease	0.00169	0.00169	CbGpPWpGaD
Crizotinib—PTK2—Axon guidance—COL9A2—degenerative disc disease	0.00161	0.00161	CbGpPWpGaD
Crizotinib—YES1—Axon guidance—COL9A2—degenerative disc disease	0.00159	0.00159	CbGpPWpGaD
Crizotinib—STK4—Signaling Pathways—COL9A2—degenerative disc disease	0.00155	0.00155	CbGpPWpGaD
Crizotinib—LCK—Signaling by PDGF—COL9A2—degenerative disc disease	0.00154	0.00154	CbGpPWpGaD
Crizotinib—LYN—Axon guidance—COL9A3—degenerative disc disease	0.00152	0.00152	CbGpPWpGaD
Crizotinib—ABL1—Axon guidance—COL9A3—degenerative disc disease	0.00151	0.00151	CbGpPWpGaD
Crizotinib—PTK2—Developmental Biology—COL9A3—degenerative disc disease	0.00147	0.00147	CbGpPWpGaD
Crizotinib—TYK2—Axon guidance—COL9A2—degenerative disc disease	0.00147	0.00147	CbGpPWpGaD
Crizotinib—YES1—Developmental Biology—COL9A3—degenerative disc disease	0.00145	0.00145	CbGpPWpGaD
Crizotinib—SRC—Oncostatin M Signaling Pathway—MMP3—degenerative disc disease	0.00144	0.00144	CbGpPWpGaD
Crizotinib—JAK2—Axon guidance—COL9A3—degenerative disc disease	0.00142	0.00142	CbGpPWpGaD
Crizotinib—ACVR1B—Signaling Pathways—COL9A3—degenerative disc disease	0.00142	0.00142	CbGpPWpGaD
Crizotinib—FER—Signaling Pathways—COL9A3—degenerative disc disease	0.00142	0.00142	CbGpPWpGaD
Crizotinib—JAK2—BDNF signaling pathway—BMP2—degenerative disc disease	0.00141	0.00141	CbGpPWpGaD
Crizotinib—SRC—Senescence and Autophagy in Cancer—BMP2—degenerative disc disease	0.00141	0.00141	CbGpPWpGaD
Crizotinib—SRC—Signaling by PDGF—COL9A2—degenerative disc disease	0.00137	0.00137	CbGpPWpGaD
Crizotinib—AXL—Signaling Pathways—COL9A3—degenerative disc disease	0.00134	0.00134	CbGpPWpGaD
Crizotinib—TYK2—Developmental Biology—COL9A3—degenerative disc disease	0.00134	0.00134	CbGpPWpGaD
Crizotinib—STK3—Signaling Pathways—COL9A2—degenerative disc disease	0.00132	0.00132	CbGpPWpGaD
Crizotinib—TXK—Immune System—PARK2—degenerative disc disease	0.00129	0.00129	CbGpPWpGaD
Crizotinib—CDK7—Disease—CHST3—degenerative disc disease	0.00123	0.00123	CbGpPWpGaD
Crizotinib—BMPR1B—Signaling Pathways—COL9A3—degenerative disc disease	0.00123	0.00123	CbGpPWpGaD
Crizotinib—LYN—Axon guidance—COL9A2—degenerative disc disease	0.00119	0.00119	CbGpPWpGaD
Crizotinib—ABL1—Axon guidance—COL9A2—degenerative disc disease	0.00118	0.00118	CbGpPWpGaD
Crizotinib—PTK2—Developmental Biology—COL9A2—degenerative disc disease	0.00115	0.00115	CbGpPWpGaD
Crizotinib—YES1—Developmental Biology—COL9A2—degenerative disc disease	0.00114	0.00114	CbGpPWpGaD
Crizotinib—JAK2—Axon guidance—COL9A2—degenerative disc disease	0.00111	0.00111	CbGpPWpGaD
Crizotinib—ACVR1B—Signaling Pathways—COL9A2—degenerative disc disease	0.0011	0.0011	CbGpPWpGaD
Crizotinib—FER—Signaling Pathways—COL9A2—degenerative disc disease	0.0011	0.0011	CbGpPWpGaD
Crizotinib—SRC—Axon guidance—COL9A3—degenerative disc disease	0.0011	0.0011	CbGpPWpGaD
Crizotinib—SRC—BDNF signaling pathway—BMP2—degenerative disc disease	0.0011	0.0011	CbGpPWpGaD
Crizotinib—LYN—Developmental Biology—COL9A3—degenerative disc disease	0.00108	0.00108	CbGpPWpGaD
Crizotinib—ABL1—Developmental Biology—COL9A3—degenerative disc disease	0.00108	0.00108	CbGpPWpGaD
Crizotinib—FES—Signaling Pathways—COL9A3—degenerative disc disease	0.00107	0.00107	CbGpPWpGaD
Crizotinib—AXL—Signaling Pathways—COL9A2—degenerative disc disease	0.00105	0.00105	CbGpPWpGaD
Crizotinib—TYK2—Developmental Biology—COL9A2—degenerative disc disease	0.00105	0.00105	CbGpPWpGaD
Crizotinib—STK4—Signaling Pathways—BMP2—degenerative disc disease	0.00103	0.00103	CbGpPWpGaD
Crizotinib—JAK2—Developmental Biology—COL9A3—degenerative disc disease	0.00101	0.00101	CbGpPWpGaD
Crizotinib—IKBKE—Immune System—PARK2—degenerative disc disease	0.000978	0.000978	CbGpPWpGaD
Crizotinib—IGF1R—Signaling Pathways—COL9A3—degenerative disc disease	0.00097	0.00097	CbGpPWpGaD
Crizotinib—RIPK2—Adaptive Immune System—PARK2—degenerative disc disease	0.000966	0.000966	CbGpPWpGaD
Crizotinib—BMPR1B—Signaling Pathways—COL9A2—degenerative disc disease	0.000958	0.000958	CbGpPWpGaD
Crizotinib—MAPK7—Signaling Pathways—COL9A3—degenerative disc disease	0.000949	0.000949	CbGpPWpGaD
Crizotinib—TYK2—Gastrin-CREB signalling pathway via PKC and MAPK—MMP3—degenerative disc disease	0.000938	0.000938	CbGpPWpGaD
Crizotinib—BLK—Adaptive Immune System—PARK2—degenerative disc disease	0.000929	0.000929	CbGpPWpGaD
Crizotinib—MAPK7—Immune System—PARK2—degenerative disc disease	0.00089	0.00089	CbGpPWpGaD
Crizotinib—LIMK1—Immune System—PARK2—degenerative disc disease	0.00089	0.00089	CbGpPWpGaD
Crizotinib—STK3—Signaling Pathways—BMP2—degenerative disc disease	0.000877	0.000877	CbGpPWpGaD
Crizotinib—CYP3A4—Metapathway biotransformation—CHST3—degenerative disc disease	0.000868	0.000868	CbGpPWpGaD
Crizotinib—SRC—Axon guidance—COL9A2—degenerative disc disease	0.000861	0.000861	CbGpPWpGaD
Crizotinib—CDK7—Gene Expression—RPL34—degenerative disc disease	0.000857	0.000857	CbGpPWpGaD
Crizotinib—LYN—Developmental Biology—COL9A2—degenerative disc disease	0.000847	0.000847	CbGpPWpGaD
Crizotinib—ABL1—Developmental Biology—COL9A2—degenerative disc disease	0.000843	0.000843	CbGpPWpGaD
Crizotinib—TYK2—Disease—CHST3—degenerative disc disease	0.000839	0.000839	CbGpPWpGaD
Crizotinib—FES—Signaling Pathways—COL9A2—degenerative disc disease	0.000837	0.000837	CbGpPWpGaD
Crizotinib—CDK7—Disease—RPL34—degenerative disc disease	0.000796	0.000796	CbGpPWpGaD
Crizotinib—JAK2—Developmental Biology—COL9A2—degenerative disc disease	0.000792	0.000792	CbGpPWpGaD
Crizotinib—SRC—Developmental Biology—COL9A3—degenerative disc disease	0.000787	0.000787	CbGpPWpGaD
Crizotinib—IGF1R—Signaling Pathways—COL9A2—degenerative disc disease	0.000757	0.000757	CbGpPWpGaD
Crizotinib—YES1—Adaptive Immune System—PARK2—degenerative disc disease	0.000747	0.000747	CbGpPWpGaD
Crizotinib—MAPK7—Signaling Pathways—COL9A2—degenerative disc disease	0.000741	0.000741	CbGpPWpGaD
Crizotinib—ACVR1B—Signaling Pathways—BMP2—degenerative disc disease	0.000735	0.000735	CbGpPWpGaD
Crizotinib—FER—Signaling Pathways—BMP2—degenerative disc disease	0.000735	0.000735	CbGpPWpGaD
Crizotinib—TBK1—Immune System—PARK2—degenerative disc disease	0.000727	0.000727	CbGpPWpGaD
Crizotinib—STK4—Signaling Pathways—MMP3—degenerative disc disease	0.000715	0.000715	CbGpPWpGaD
Crizotinib—JAK2—Gastrin-CREB signalling pathway via PKC and MAPK—MMP3—degenerative disc disease	0.000711	0.000711	CbGpPWpGaD
Crizotinib—JAK3—Signaling Pathways—COL9A3—degenerative disc disease	0.000701	0.000701	CbGpPWpGaD
Crizotinib—AXL—Signaling Pathways—BMP2—degenerative disc disease	0.000697	0.000697	CbGpPWpGaD
Crizotinib—MAP3K3—Immune System—PARK2—degenerative disc disease	0.000697	0.000697	CbGpPWpGaD
Crizotinib—JAK3—Immune System—PARK2—degenerative disc disease	0.000657	0.000657	CbGpPWpGaD
Crizotinib—BMPR1B—Signaling Pathways—BMP2—degenerative disc disease	0.000637	0.000637	CbGpPWpGaD
Crizotinib—JAK2—Disease—CHST3—degenerative disc disease	0.000636	0.000636	CbGpPWpGaD
Crizotinib—RIPK2—Signaling Pathways—COL9A3—degenerative disc disease	0.000625	0.000625	CbGpPWpGaD
Crizotinib—PTK2B—Signaling Pathways—COL9A3—degenerative disc disease	0.000616	0.000616	CbGpPWpGaD
Crizotinib—SRC—Developmental Biology—COL9A2—degenerative disc disease	0.000614	0.000614	CbGpPWpGaD
Crizotinib—STK3—Signaling Pathways—MMP3—degenerative disc disease	0.000608	0.000608	CbGpPWpGaD
Crizotinib—NTRK1—Signaling Pathways—COL9A3—degenerative disc disease	0.00059	0.00059	CbGpPWpGaD
Crizotinib—RIPK2—Immune System—PARK2—degenerative disc disease	0.000586	0.000586	CbGpPWpGaD
Crizotinib—MAPK7—Signaling by GPCR—MMP3—degenerative disc disease	0.000579	0.000579	CbGpPWpGaD
Crizotinib—PTK2B—Immune System—PARK2—degenerative disc disease	0.000577	0.000577	CbGpPWpGaD
Crizotinib—RPS6KB1—Signaling Pathways—COL9A3—degenerative disc disease	0.000572	0.000572	CbGpPWpGaD
Crizotinib—BLK—Immune System—PARK2—degenerative disc disease	0.000563	0.000563	CbGpPWpGaD
Crizotinib—FGR—Immune System—PARK2—degenerative disc disease	0.000562	0.000562	CbGpPWpGaD
Crizotinib—LYN—Adaptive Immune System—PARK2—degenerative disc disease	0.000557	0.000557	CbGpPWpGaD
Crizotinib—FES—Signaling Pathways—BMP2—degenerative disc disease	0.000557	0.000557	CbGpPWpGaD
Crizotinib—LCK—Disease—CHST3—degenerative disc disease	0.000557	0.000557	CbGpPWpGaD
Crizotinib—JAK3—Signaling Pathways—COL9A2—degenerative disc disease	0.000547	0.000547	CbGpPWpGaD
Crizotinib—TYK2—Disease—RPL34—degenerative disc disease	0.000541	0.000541	CbGpPWpGaD
Crizotinib—FER—Signaling Pathways—MMP3—degenerative disc disease	0.00051	0.00051	CbGpPWpGaD
Crizotinib—ACVR1B—Signaling Pathways—MMP3—degenerative disc disease	0.00051	0.00051	CbGpPWpGaD
Crizotinib—IGF1R—Signaling Pathways—BMP2—degenerative disc disease	0.000504	0.000504	CbGpPWpGaD
Crizotinib—SRC—Disease—CHST3—degenerative disc disease	0.000493	0.000493	CbGpPWpGaD
Crizotinib—MAPK7—Signaling Pathways—BMP2—degenerative disc disease	0.000493	0.000493	CbGpPWpGaD
Crizotinib—PTK2—Signaling Pathways—COL9A3—degenerative disc disease	0.000491	0.000491	CbGpPWpGaD
Crizotinib—RIPK2—Signaling Pathways—COL9A2—degenerative disc disease	0.000488	0.000488	CbGpPWpGaD
Crizotinib—YES1—Signaling Pathways—COL9A3—degenerative disc disease	0.000484	0.000484	CbGpPWpGaD
Crizotinib—AXL—Signaling Pathways—MMP3—degenerative disc disease	0.000483	0.000483	CbGpPWpGaD
Crizotinib—PTK2B—Signaling Pathways—COL9A2—degenerative disc disease	0.000481	0.000481	CbGpPWpGaD
Crizotinib—NTRK1—Signaling Pathways—COL9A2—degenerative disc disease	0.00046	0.00046	CbGpPWpGaD
Crizotinib—PTK2—Immune System—PARK2—degenerative disc disease	0.00046	0.00046	CbGpPWpGaD
Crizotinib—IRAK1—Signaling Pathways—COL9A3—degenerative disc disease	0.000459	0.000459	CbGpPWpGaD
Crizotinib—LCK—Adaptive Immune System—PARK2—degenerative disc disease	0.000457	0.000457	CbGpPWpGaD
Crizotinib—YES1—Immune System—PARK2—degenerative disc disease	0.000453	0.000453	CbGpPWpGaD
Crizotinib—RPS6KB1—Signaling Pathways—COL9A2—degenerative disc disease	0.000446	0.000446	CbGpPWpGaD
Crizotinib—TYK2—Signaling Pathways—COL9A3—degenerative disc disease	0.000445	0.000445	CbGpPWpGaD
Crizotinib—BMPR1B—Signaling Pathways—MMP3—degenerative disc disease	0.000442	0.000442	CbGpPWpGaD
Crizotinib—IRAK1—Immune System—PARK2—degenerative disc disease	0.00043	0.00043	CbGpPWpGaD
Crizotinib—JAK3—Signaling by GPCR—MMP3—degenerative disc disease	0.000427	0.000427	CbGpPWpGaD
Crizotinib—TYK2—Immune System—PARK2—degenerative disc disease	0.000417	0.000417	CbGpPWpGaD
Crizotinib—JAK2—Disease—RPL34—degenerative disc disease	0.00041	0.00041	CbGpPWpGaD
Crizotinib—SRC—Adaptive Immune System—PARK2—degenerative disc disease	0.000404	0.000404	CbGpPWpGaD
Crizotinib—FES—Signaling Pathways—MMP3—degenerative disc disease	0.000386	0.000386	CbGpPWpGaD
Crizotinib—PTK2—Signaling Pathways—COL9A2—degenerative disc disease	0.000383	0.000383	CbGpPWpGaD
Crizotinib—YES1—Signaling Pathways—COL9A2—degenerative disc disease	0.000378	0.000378	CbGpPWpGaD
Crizotinib—JAK3—Signaling Pathways—BMP2—degenerative disc disease	0.000364	0.000364	CbGpPWpGaD
Crizotinib—LYN—Signaling Pathways—COL9A3—degenerative disc disease	0.000361	0.000361	CbGpPWpGaD
Crizotinib—LCK—Disease—RPL34—degenerative disc disease	0.000359	0.000359	CbGpPWpGaD
Crizotinib—IRAK1—Signaling Pathways—COL9A2—degenerative disc disease	0.000358	0.000358	CbGpPWpGaD
Crizotinib—IGF1R—Signaling Pathways—MMP3—degenerative disc disease	0.000349	0.000349	CbGpPWpGaD
Crizotinib—TYK2—Signaling Pathways—COL9A2—degenerative disc disease	0.000348	0.000348	CbGpPWpGaD
Crizotinib—MAPK7—Signaling Pathways—MMP3—degenerative disc disease	0.000342	0.000342	CbGpPWpGaD
Crizotinib—LYN—Immune System—PARK2—degenerative disc disease	0.000338	0.000338	CbGpPWpGaD
Crizotinib—JAK2—Signaling Pathways—COL9A3—degenerative disc disease	0.000338	0.000338	CbGpPWpGaD
Crizotinib—ABL1—Immune System—PARK2—degenerative disc disease	0.000336	0.000336	CbGpPWpGaD
Crizotinib—RIPK2—Signaling Pathways—BMP2—degenerative disc disease	0.000325	0.000325	CbGpPWpGaD
Crizotinib—CYP3A5—Metabolism—CHST3—degenerative disc disease	0.000324	0.000324	CbGpPWpGaD
Crizotinib—PTK2B—Signaling Pathways—BMP2—degenerative disc disease	0.00032	0.00032	CbGpPWpGaD
Crizotinib—SRC—Disease—RPL34—degenerative disc disease	0.000318	0.000318	CbGpPWpGaD
Crizotinib—JAK2—Immune System—PARK2—degenerative disc disease	0.000316	0.000316	CbGpPWpGaD
Crizotinib—NTRK1—Signaling Pathways—BMP2—degenerative disc disease	0.000306	0.000306	CbGpPWpGaD
Crizotinib—RPS6KB1—Signaling Pathways—BMP2—degenerative disc disease	0.000297	0.000297	CbGpPWpGaD
Crizotinib—LCK—Signaling Pathways—COL9A3—degenerative disc disease	0.000296	0.000296	CbGpPWpGaD
Crizotinib—LYN—Signaling Pathways—COL9A2—degenerative disc disease	0.000282	0.000282	CbGpPWpGaD
Crizotinib—LCK—Immune System—PARK2—degenerative disc disease	0.000277	0.000277	CbGpPWpGaD
Crizotinib—TYK2—Signaling by GPCR—MMP3—degenerative disc disease	0.000271	0.000271	CbGpPWpGaD
Crizotinib—JAK2—Signaling Pathways—COL9A2—degenerative disc disease	0.000264	0.000264	CbGpPWpGaD
Crizotinib—SRC—Signaling Pathways—COL9A3—degenerative disc disease	0.000262	0.000262	CbGpPWpGaD
Crizotinib—PTK2—Signaling Pathways—BMP2—degenerative disc disease	0.000255	0.000255	CbGpPWpGaD
Crizotinib—JAK3—Signaling Pathways—MMP3—degenerative disc disease	0.000252	0.000252	CbGpPWpGaD
Crizotinib—YES1—Signaling Pathways—BMP2—degenerative disc disease	0.000251	0.000251	CbGpPWpGaD
Crizotinib—SRC—Immune System—PARK2—degenerative disc disease	0.000245	0.000245	CbGpPWpGaD
Crizotinib—ABCB1—Metabolism—CHST3—degenerative disc disease	0.000244	0.000244	CbGpPWpGaD
Crizotinib—IRAK1—Signaling Pathways—BMP2—degenerative disc disease	0.000238	0.000238	CbGpPWpGaD
Crizotinib—TYK2—Signaling Pathways—BMP2—degenerative disc disease	0.000231	0.000231	CbGpPWpGaD
Crizotinib—LCK—Signaling Pathways—COL9A2—degenerative disc disease	0.000231	0.000231	CbGpPWpGaD
Crizotinib—RIPK2—Signaling Pathways—MMP3—degenerative disc disease	0.000225	0.000225	CbGpPWpGaD
Crizotinib—PTK2B—Signaling Pathways—MMP3—degenerative disc disease	0.000222	0.000222	CbGpPWpGaD
Crizotinib—NTRK1—Signaling Pathways—MMP3—degenerative disc disease	0.000212	0.000212	CbGpPWpGaD
Crizotinib—RPS6KB1—Signaling Pathways—MMP3—degenerative disc disease	0.000206	0.000206	CbGpPWpGaD
Crizotinib—JAK2—Signaling by GPCR—MMP3—degenerative disc disease	0.000206	0.000206	CbGpPWpGaD
Crizotinib—SRC—Signaling Pathways—COL9A2—degenerative disc disease	0.000204	0.000204	CbGpPWpGaD
Crizotinib—LYN—Signaling Pathways—BMP2—degenerative disc disease	0.000187	0.000187	CbGpPWpGaD
Crizotinib—PTK2—Signaling Pathways—MMP3—degenerative disc disease	0.000177	0.000177	CbGpPWpGaD
Crizotinib—JAK2—Signaling Pathways—BMP2—degenerative disc disease	0.000175	0.000175	CbGpPWpGaD
Crizotinib—YES1—Signaling Pathways—MMP3—degenerative disc disease	0.000174	0.000174	CbGpPWpGaD
Crizotinib—IRAK1—Signaling Pathways—MMP3—degenerative disc disease	0.000165	0.000165	CbGpPWpGaD
Crizotinib—TYK2—Signaling Pathways—MMP3—degenerative disc disease	0.00016	0.00016	CbGpPWpGaD
Crizotinib—LCK—Signaling Pathways—BMP2—degenerative disc disease	0.000154	0.000154	CbGpPWpGaD
Crizotinib—CYP3A4—Metabolism—CHST3—degenerative disc disease	0.000151	0.000151	CbGpPWpGaD
Crizotinib—SRC—Signaling Pathways—BMP2—degenerative disc disease	0.000136	0.000136	CbGpPWpGaD
Crizotinib—LYN—Signaling Pathways—MMP3—degenerative disc disease	0.00013	0.00013	CbGpPWpGaD
Crizotinib—JAK2—Signaling Pathways—MMP3—degenerative disc disease	0.000122	0.000122	CbGpPWpGaD
Crizotinib—LCK—Signaling Pathways—MMP3—degenerative disc disease	0.000106	0.000106	CbGpPWpGaD
Crizotinib—SRC—Signaling Pathways—MMP3—degenerative disc disease	9.42e-05	9.42e-05	CbGpPWpGaD
